<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-132926</identifier>
<setSpec>0034-9356</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Beta-blockers in septic shock: a review</dc:title>
<dc:description xml:lang="en">In septic shock, high adrenergic stress is associated with cardiovascular and systemic adverse effects, which can negatively affect the results. Beta-adrenergic receptor block has been shown to be effective in controlling the disproportionate increase in heart rate, maintaining a favorable hemodynamic profile and apparently improving the efficiency of the cardiovascular system in order to maintain tissue perfusion. They have also been shown to modulate favorably catecholamine-induced immunosuppression and to decrease insulin resistance, protein catabolism, and proinflammatory cytokine expression associated with cardiovascular dysfunction. Selective beta-1 blockers appear to provide better results than non-selective blockers, even suggesting a positive impact on mortality. Future clinical trials are still needed to confirm these findings and define the scope of their benefits (AU)</dc:description>
<dc:creator>Aguilar, J. L</dc:creator>
<dc:creator>Vela-Vásquez, R. S</dc:creator>
<dc:creator>Grigorov-Tzenkov, I</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">La excesiva estimulación simpática está asociada con efectos adversos a nivel cardiovascular y sistémico, que pueden afectar negativamente los resultados en el shock séptico. El bloqueo de los receptores beta adrenérgicos ha mostrado controlar eficazmente el incremento desproporcionado de la frecuencia cardiaca, conservando un perfil hemodinámico favorable y al parecer mejorando la eficiencia del sistema cardiovascular para mantener la perfusión tisular. Adicionalmente, ha mostrado modular favorablemente la inmunosupresión inducida por catecolaminas, así como disminuir la resistencia a la insulina, el catabolismo proteico y la expresión de citocinas proinflamatorias asociadas a disfunción cardiovascular. El bloqueo selectivo de los receptores beta-1 parece ofrecer mejores resultados que el bloqueo no selectivo, sugiriendo incluso un impacto positivo en la mortalidad. Son necesarios futuros ensayos clínicos para confirmar estos hallazgos y definir los alcances de estos beneficios (AU)</dc:description>
<dc:source>Rev Esp Anestesiol Reanim;62(2): 90-95, feb. 2015. ilus</dc:source>
<dc:identifier>ibc-132926</dc:identifier>
<dc:title xml:lang="es">Bloqueadores beta en shock séptico: una revisión</dc:title>
<dc:subject>^d29611</dc:subject>
<dc:subject>^d13944^s22021</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d13150^s22057</dc:subject>
<dc:subject>^d32031^s22057</dc:subject>
<dc:subject>^d29540^s22021</dc:subject>
<dc:subject>^d31983^s22012</dc:subject>
<dc:subject>^d31983^s22057</dc:subject>
<dc:subject>^d29540^s22073</dc:subject>
<dc:subject>^d1348^s22074</dc:subject>
<dc:subject>^d6493^s22021</dc:subject>
<dc:subject>^d32031^s22012</dc:subject>
<dc:type>article</dc:type>
<dc:date>201502</dc:date>
</metadata>
</record>
</ibecs-document>
